Real-time enrollment status for this delayed sleep-wake phase disorder clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:36 AM UTC
| NCT Number | NCT04652882 |
| Recruiting Status | Recruiting |
| Condition | Delayed Sleep-Wake Phase Disorder |
| Phase | PHASE3 |
| Target Enrollment | 70 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | December 2, 2025 (Dec 2, 2025) |
As of July 17, 2026: Clinical trial NCT04652882 is currently recruiting participants. This phase3 study for delayed sleep-wake phase disorder is actively seeking new participants at 11 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04652882 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04652882 was last updated Dec 2, 2025 (December 2, 2025). HelloStudys verifies this status automatically.